Steven Μ. Albelda

3 ta ish

University of Pennsylvania

1. Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccines

   Edmund K. Moon, Liang‐Chuan S. Wang, Kheng Bekdache +4

   MaqolaOAOchiq kirish20172 iqtibos

   ABIABI:AkademIndex/2026.other.020489

2. Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies

   Gregory L. Beatty, Andrew R. Haas, Marcela V. Maus +9

   MaqolaOAOchiq kirish20132 iqtibos

   ABIABI:AkademIndex/2026.other.082777

3. Mesothelin-targeted CAR-T cell therapy for solid tumors

   Astero Klampatsa, Paraskevi Dimou, Steven Μ. Albelda

   Maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.431566